Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 123 for:    lucerne

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03823300
Recruitment Status : Active, not recruiting
First Posted : January 30, 2019
Last Update Posted : October 19, 2021
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 5, 2020
Estimated Study Completion Date : September 6, 2023
Certification/Extension First Submitted : September 1, 2021